Clinical Trial Update: Splenectomy as a Treatment for Patient With Relapsed Haemophagocytic Lymphohistiocytosis of Unknown Etiology [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial exploring splenectomy as a treatment for relapsed hemophagocytic lymphohistiocytosis of unknown etiology. The study is listed as Phase 2/Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophagocytic Lymphohistiocytosis

Drugs mentioned

• Splenectomy

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Hemophagocytic Lymphohistiocytosis | Phase 2, Phase 3 | Status: UNKNOWN